LivingGLP1
Study S002684

The Effects of GLP-1 Receptor Agonists on Sensory Systems and Ingestive Behavior

ClinicalTrials.gov record

Registration

Registration
NCT07611201
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
90
Start
2025-02-20
Primary completion
2026-05-04
Lead sponsor
Purdue University
Conditions
Obesity; Overweight; Taste Perception; Olfaction; Eating Behavior; Appetite
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Taste Detection Thresholds [During study participation, up to 2 weeks]
  • Suprathreshold Taste Intensity [During study participation, up to 2 weeks]
  • Taste Hedonics [During study participation, up to 2 weeks]
  • Fat Taste Intensity Rating [During study participation, up to 2 weeks]
  • ArOMa-T Olfactory Test Performance [During study participation, up to 2 weeks]
  • SCENTinel Olfactory Test Performance [During study participation, up to 2 weeks]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0000457The effects of glucagon-like peptide-1 receptor agonists on chemosensory function and ingestive behavior.
Rutigliani G, Physiology & behavior
2026Nonrandomized studyPMID 42641845DOIcites ClinicalTrials.gov:NCT07611201; registry reference DERIVED:42641845
R0019135GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity.
Kadouh H, The Journal of clinical endocrinology and metabolism
2020Randomized trialPMID 31665455DOIregistry reference BACKGROUND:31665455